API
TEVA icon

Asset Planning Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Asset Planning Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Hold
400
– – 0.01% 242
2026
Q1 		$12K Hold
400
– – 0.01% 231
2025
Q4 		$12.5K Hold
400
– – 0.01% 225
2025
Q3 		$8.08K Hold
400
– – 0.01% 241
2025
Q2 		$6.7K Hold
400
– – 0.01% 244
2025
Q1 		$6.15K Hold
400
– – ﹤0.01% 251
2024
Q4 		$8.82K Buy
+400
New +$7.28K 0.01% 251

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Asset Planning Inc's TEVA Position: Q2 2026 in Review

Asset Planning Inc held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 400 shares worth $13.6K. The position accounts for 0.01% of the portfolio, ranked #242.

Asset Planning Inc first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Asset Planning Inc held 400 shares of Teva Pharmaceuticals worth $13.6K as of Q2 2026.
  • Asset Planning Inc left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.01% of Asset Planning Inc's portfolio in Q2 2026, its #242 holding.
  • Asset Planning Inc first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.